{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T07:23:37Z","timestamp":1789629817651,"version":"build-2803163510"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012669","name":"Natural Science Foundation Project of Chongqing, Chongqing Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012669","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Optimizing immunosuppression based on immunological risk profiles remains the preferred regimen for improving long-term graft outcomes after renal transplantation. Tacrolimus (TAC), the cornerstone drug of the calcineurin inhibitors, is currently the most commonly used immunosuppressant for renal transplantation. Under-exposure can lead to rejection events, while overexposure has been shown to cause drug-related renal injury. This study aims to assess the impact of TAC exposure on graft renal function to identify high-risk individuals of post-transplantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The present study employed a single-center retrospective cohort design to enroll adult recipients who underwent allogeneic kidney transplantation from 1 January 2019 to 31 December 2023. Cox regression analysis was used to analyze the independent risk effects of exposure parameters, which included mean, median, standard deviation (STD) and coefficient of variation (CV). Hereafter, the Kaplan-Meier method was applied to perform the survival analysis of stabilized graft renal function.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>69 cases (19.22%) in the study cohort developed graft renal insufficiency. And a STD of TAC target trough concentration\u22655 was associated with a 4.55-fold elevated risk (95% CI 1.60-12.95, p = 0.004). Recipients in the higher CV had an increased risk of graft renal insufficiency in comparison with those in low CV tertile. As indicated by the survival analysis curves, it was determined that TAC mean trough concentrations &amp;gt;8 ng\/mL, CV&amp;gt;0.5 and TTR&amp;lt;0.3 were associated with a higher risk of graft renal insufficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Higher TAC trough concentrations, higher CV, and lower TTR post-transplantation significantly increases the risk of transplant renal insufficiency. Identifying these high-risk transplant recipients, correcting potentially influential factors and keeping TAC within recommended concentrations will significantly improve the outcomes and survival of renal transplant recipients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1656392","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:22:57Z","timestamp":1770960177000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevated tacrolimus exposure variability predicts transplant renal insufficiency"],"prefix":"10.3389","volume":"17","author":[{"given":"Yue","family":"Zhao","sequence":"first","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Army Medical University (Third Military Medical University)","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying-Xin","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Daping Hospital, Army Medical University (Third Military Medical University)","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Army Medical University (Third Military Medical University)","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, the First Affiliated Hospital of Army Medical University (Third Military Medical University)","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, the First Affiliated Hospital of Army Medical University (Third Military Medical University)","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfw444","article-title":"The clinical epidemiology of young adults starting renal replacement therapy in the UK: presentation, management and survival using 15 years of UK renal registry data","volume":"33","author":"Hamilton","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"B2","doi-asserted-by":"publisher","first-page":"e068769","DOI":"10.1136\/bmj-2021-068769","article-title":"Survival for waitlisted kidney failure patients receiving transplantation versus remaining on waiting list: systematic review and meta-analysis","volume":"376","author":"Chaudhry","year":"2022","journal-title":"BMJ"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfab232","article-title":"Mapping health-related quality of life after kidney transplantation by group comparisons: A systematic review","volume":"36","author":"Wang","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.1618","article-title":"Intrapatient variability of tacrolimus exposure in solid organ transplantation: A novel marker for clinical outcome","volume":"107","author":"Kuypers","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"B5","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1016\/j.ajt.2023.02.004","article-title":"OPTN\/SRTR 2021 annual data report: kidney","volume":"23","author":"Lentine","year":"2023","journal-title":"Am J Transplant"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2016.10.006","article-title":"Immunosuppression for kidney transplantation: where are we now and where are we going","volume":"31","author":"Lim","year":"2017","journal-title":"Transplant Rev (Orlando)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/08923973.2021.1966033","article-title":"Transplantation and immunosuppression: A review of novel transplant-related immunosuppressant drugs","volume":"43","author":"Parlakpinar","year":"2021","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"e14190","DOI":"10.1111\/apha.14190","article-title":"Immunosuppression with cyclosporine versus tacrolimus shows distinctive nephrotoxicity profiles within renal compartments","volume":"240","author":"Demirci","year":"2024","journal-title":"Acta Physiol (Oxf)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2023.2250251","article-title":"Individualized dosing algorithms for tacrolimus in kidney transplant recipients: current status and unmet needs","volume":"19","author":"Schagen","year":"2023","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0000000000000979","article-title":"Model-based tacrolimus follow-up dosing in adult renal transplant recipients: A simulation trial","volume":"44","author":"Francke","year":"2022","journal-title":"Ther Drug Monit"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200363120-00006","article-title":"Tacrolimus: A further update of its use in the management of organ transplantation","volume":"63","author":"Scott","year":"2003","journal-title":"Drugs"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16002","article-title":"A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation","volume":"20","author":"Gonzales","year":"2020","journal-title":"Am J Transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2024.100842","article-title":"Tacrolimus intra-patient variability measures and its associations with allograft clinical outcomes in kidney transplantation","volume":"38","author":"Xie","year":"2024","journal-title":"Transplant Rev (Orlando)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02643-y","article-title":"Reduction of exposure to tacrolimus trough level variability is associated with better graft survival after kidney transplantation","volume":"75","author":"Rahamimov","year":"2019","journal-title":"Eur J Clin Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/bcp.14876","article-title":"Tacrolimus variability score outperforms coefficient of variation in predicting clinical outcomes of living kidney transplantation","volume":"88","author":"Yin","year":"2021","journal-title":"Br J Clin Pharmacol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14504","article-title":"Lower tacrolimus exposure and time in therapeutic range increase the risk of de novo donor-specific antibodies in the first year of kidney transplantation","volume":"18","author":"Davis","year":"2017","journal-title":"Am J Transplant"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn421203-20240418-00092","article-title":"Chinese clinical practice guidelines for immunosuppressive therapy in kidney transplant recipients (2023 edition)","volume":"45","author":"Xue","year":"2024","journal-title":"Chin J Organ Transplant"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e22587","DOI":"10.1002\/jcla.22587","article-title":"Comparison of whole-blood tacrolimus concentrations measured by different immunoassay systems","volume":"32","author":"Kaneko","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15346","article-title":"Late intra-patient tacrolimus trough level variability as a major problem in kidney transplantation: A collaborative transplant study report","volume":"19","author":"S\u00fcsal","year":"2019","journal-title":"Am J Transplant"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14944","article-title":"Tacrolimus prevents von willebrand factor secretion by allostimulated human glomerular endothelium","volume":"18","author":"B\u00e9land","year":"2018","journal-title":"Am J Transplant"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/tri.12798","article-title":"A high intrapatient variability in tacrolimus exposure is associated with poor long-term outcome of kidney transplantation","volume":"29","author":"Shuker","year":"2016","journal-title":"Transpl Int"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.3390\/ijms26051960","article-title":"Trends in precision medicine and pharmacogenetics as an adjuvant in establishing a correct immunosuppressive therapy for kidney transplant: an up-to-date historical overview","volume":"26","author":"Belardi","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2015.03.017","article-title":"Patients\u2019 Time in therapeutic range on warfarin among US patients with atrial fibrillation: results from ORBIT-AF registry","volume":"170","author":"Pokorney","year":"2015","journal-title":"Am Heart J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2011.07.004","article-title":"Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation","volume":"129","author":"Lind","year":"2012","journal-title":"Thromb Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/dom.14906","article-title":"Continuous glucose monitoring metrics (Mean glucose, time above range and time in range) are superior to glycated haemoglobin for assessment of therapeutic efficacy","volume":"25","author":"Rodbard","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1177\/10600280241302412","article-title":"Evaluation of the incidence of nocardia infection in solid organ transplant recipients on trimethoprim-sulfamethoxazole for opportunistic infection prophylaxis","volume":"59","author":"Jung","year":"2025","journal-title":"Ann Pharmacother"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-024-01726-w","article-title":"Impact of intra-patient variability of tacrolimus on allograft function and CD4\u2009+\u2009\/CD8\u2009+\u2009Ratio in kidney transplant recipients: A retrospective single-center study","volume":"46","author":"Wang","year":"2024","journal-title":"Int J Clin Pharm"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1911281116","article-title":"Predicting kidney transplant outcomes with partial knowledge of HLA mismatch","volume":"116","author":"Manski","year":"2019","journal-title":"Proc Natl Acad Sci U.S.A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2270078","article-title":"Sex-specific time trends of long-term graft survival after kidney transplantation - a registry-based study","volume":"45","author":"Nasic","year":"2023","journal-title":"Ren Fail"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1097\/TP.0000000000004915","article-title":"A multinational cohort study examining sex differences in excess risk of death with graft function after kidney transplant","volume":"108","author":"Vinson","year":"2024","journal-title":"Transplantation"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.304","article-title":"Each additional hour of cold ischemia time significantly increases the risk of graft failure and mortality following renal transplantation","volume":"87","author":"Debout","year":"2015","journal-title":"Kidney Int"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1622702","article-title":"Comparing Tacrolimus Level Monitoring in Peripheral Blood Mononuclear Cells and Whole Blood within One Year after Kidney Transplantation: A Single-Center, Prospective, Observational Study","volume":"16","author":"You","year":"2025","journal-title":"Front Pharmacol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1656392\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T05:22:58Z","timestamp":1770960178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1656392\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":32,"alternative-id":["10.3389\/fimmu.2026.1656392"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1656392","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]},"article-number":"1656392"}}